Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.7.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2017
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
Franchised clinics:   2017   2016   2017   2016
Clinics open at beginning of period    
326
      
277
      
309
      
265
  
Opened or purchased during the period    
11
      
11
      
29
      
25
  
Acquired during the period    
-
      
(6
 )    
-
      
(6
 )
Closed during the period    
(1
 )    
(2
 )    
(2
 )    
(4
 )
Clinics in operation at the end of the period    
336
      
280
      
336
      
280
  
    Three Months Ended
June 30,		   Six Months Ended
June 30,
Company-owned or managed clinics:   2017   2016   2017   2016
Clinics open at beginning of period    
47
      
54
      
61
      
47
  
Opened during the period    
-
      
1
      
-
      
8
  
Acquired during the period    
-
      
6
      
-
      
6
  
Closed or sold during the period    
-
      
-
      
(14
 )    
-
  
Clinics in operation at the end of the period    
47
      
61
      
47
      
61
  
                                 
Total clinics in operation at the end of the period    
383
      
341
      
383
      
341
  
                                 
Clinics licenses sold but not yet developed    
109
      
134
      
109
      
134
  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2017   2016   2017   2016
                 
Net loss   $
(1,011,162
 )   $
(3,261,382
 )   $
(2,658,227
 )   $
(6,786,515
 )
                                 
Weighted average common shares outstanding - basic    
13,127,255
      
12,672,974
      
13,085,159
      
12,620,438
  
Effect of dilutive securities:                                
Stock options    
-
      
-
      
-
      
-
  
Weighted average common shares outstanding - diluted    
13,127,255
      
12,672,974
      
13,085,159
      
12,620,438
  
                                 
Basic and diluted loss per share   $
(0.08
 )   $
(0.26
 )   $
(0.20
 )   $
(0.54
 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2017   2016   2017   2016
Unvested restricted stock    
65,700
      
151,806
      
65,700
      
151,806
  
Stock options    
1,044,286
      
787,955
      
1,044,286
      
787,955
  
Warrants    
90,000
      
90,000
      
90,000
      
90,000